BioCatalystWatch
IBIOWorkspace / IBIO / OverviewCompany library
Price
Market cap
Next catalystDec 2, 2026Amylin Antibody · Data readoutCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

IBIO-610

Activin E

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

IBIO-600

Myostatin (GDF8) × GDF11

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

IBIO-800

Myostatin (GDF8) × GDF11 × Activin A

Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

IBIO-610

Activin E

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

IBIO-600

Myostatin (GDF8) × GDF11

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

IBIO-800

Myostatin (GDF8) × GDF11 × Activin A

Upcoming / outlook

Other pipelines

Amylin Antibody

Amylin receptor

IBIO-600

Myostatin (GDF8) × GDF11

IBIO-600

Myostatin (GDF8) × GDF11

IBIO-800

Myostatin (GDF8) × GDF11 × Activin A

CCR8

EGFRvIII

EGFRvIII

TROP-2 × CD3

Partner / License out

PD-1

PreINDP1P2P3FilingApproved

History / paused

SARS-CoV-2 spike antigen

PreINDP1P2P3FilingApproved

SARS-CoV-2 RBM

PreINDP1P2P3FilingApproved

SARS-CoV-2 nucleocapsid (N) protein

PreINDP1P2P3FilingApproved

MUC16 × CD3

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

IBIO SEC archive